Cirillo, A.; Zizzari, I.G.; Botticelli, A.; Strigari, L.; Rahimi, H.; Scagnoli, S.; Scirocchi, F.; Pernazza, A.; Pace, A.; Cerbelli, B.;
et al. Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients. Int. J. Mol. Sci. 2023, 24, 7114.
https://doi.org/10.3390/ijms24087114
AMA Style
Cirillo A, Zizzari IG, Botticelli A, Strigari L, Rahimi H, Scagnoli S, Scirocchi F, Pernazza A, Pace A, Cerbelli B,
et al. Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients. International Journal of Molecular Sciences. 2023; 24(8):7114.
https://doi.org/10.3390/ijms24087114
Chicago/Turabian Style
Cirillo, Alessio, Ilaria Grazia Zizzari, Andrea Botticelli, Lidia Strigari, Hassan Rahimi, Simone Scagnoli, Fabio Scirocchi, Angelina Pernazza, Angelica Pace, Bruna Cerbelli,
and et al. 2023. "Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients" International Journal of Molecular Sciences 24, no. 8: 7114.
https://doi.org/10.3390/ijms24087114
APA Style
Cirillo, A., Zizzari, I. G., Botticelli, A., Strigari, L., Rahimi, H., Scagnoli, S., Scirocchi, F., Pernazza, A., Pace, A., Cerbelli, B., d’Amati, G., Marchetti, P., Nuti, M., Rughetti, A., & Napoletano, C.
(2023). Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients. International Journal of Molecular Sciences, 24(8), 7114.
https://doi.org/10.3390/ijms24087114
